Eli Estey
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 12
- Hematopoietic Stem Cell Transplantation 1
-
- Parkinson's Disease Mechanisms and Treatments 4
- Co-authors
- Hagop M. Kantarjian (8 shared papers)Zekaver Odabaşı (1 shared paper)John H. Rex (1 shared paper)Richard J. Ridge (1 shared paper)Paul A. Ketchum (1 shared paper)Luis Ostrosky‐Zeichner (1 shared paper)Malcolm Finkelman (1 shared paper)Gloria N. Mattiuzzi (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Blood (3 papers)Neurology (2 papers)New England Journal of Medicine (2 papers)Leukemia (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Eli Estey
25 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 75
- Hematology 508
- Infectious Diseases 472
- Genetics 177
- Molecular Biology 558
- Neurology 123
Countries citing papers authored by Eli Estey
This map shows the geographic impact of Eli Estey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Estey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Estey more than expected).
Fields of papers citing papers by Eli Estey
This network shows the impact of papers produced by Eli Estey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Estey. The network helps show where Eli Estey may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Estey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 534 | |
| 2 | 2008 | 319 | |
| 3 | 2009 | 298 | |
| 4 | 1976 | 114 | |
| 5 | 1997 | 113 | |
| 6 | 1994 | 112 | |
| 7 | 1997 | 95 | |
| 8 | The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics. | 1999 | 76 |
| 9 | 1992 | 62 | |
| 10 | 2007 | 45 | |
| 11 | 2004 | 44 | |
| 12 | 1979 | 43 | |
| 13 | 1999 | 19 | |
| 14 | Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study. | 1998 | 16 |
| 15 | 1976 | 15 | |
| 16 | 1979 | 13 | |
| 17 | 2004 | 13 | |
| 18 | 2002 | 10 | |
| 19 | 2007 | 7 | |
| 20 | 2007 | 6 |
About Eli Estey
Eli Estey is a scholar working on Hematology, Neurology, Molecular Biology, Genetics and Computational Theory and Mathematics, having authored 25 papers that have together received 2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Retinoids in leukemia and cellular processes (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Cancer therapeutics and mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Antifungal resistance and susceptibility (1 paper), Multiple and Secondary Primary Cancers (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Hematology (508 citations), Infectious Diseases (472 citations), Genetics (177 citations), Molecular Biology (558 citations) and Neurology (123 citations). Eli Estey has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Hagop M. Kantarjian, Zekaver Odabaşı, John H. Rex, Richard J. Ridge, Paul A. Ketchum, Luis Ostrosky‐Zeichner, Malcolm Finkelman, Gloria N. Mattiuzzi, Mark J. Kupersmith and Menek Goldstein. Their work appears in journals such as Journal of Clinical Oncology, Blood, Neurology, New England Journal of Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.